Dabigatran etexilate Terminated Phase 4 Trials for Coronary Heart Disease (CHD) / Acute Coronary Syndromes (ACS) / Atherosclerosis / Nonvalvular Atrial Fibrillation Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01352702Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation